Nkarta selected for ACR Convergence 2026 autoimmune NKX019 presentations
Nkarta said it was selected for three scientific presentations at ACR Convergence 2026, where it will present initial autoimmune clinical data for NKX019.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Nkarta to present initial autoimmune clinical data for NKX019 at ACR Convergence 2026
Nkarta plans to present initial autoimmune clinical data for NKX019 at ACR Convergence 2026.